TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
AMRZ

Amrize Ltd

Basic Materials · Building Materials

40.80$ -1.9% vs. previous close Closing price · As of: Nov 12, 2026

Investor relations

Report Dates

Investor relations overview for Amrize Ltd (AMRZ): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/28/2026.

Next report 10/28/2026
Last report 10/28/2026
Earnings surprise by quarter (%)
Q2 25 · -31.0 % 25 Q3 25 · 9.7 % 25 Q4 25 · 0.0 % 25 Q1 26 · -50.0 % 26 Q2 26 · -4.4 % 26 Q3 26 · 4.1 % 26

EPS estimate beaten

Full history 2 of 7 quarters (29%)

Earnings Call Transcripts

Search all transcripts →

  • 10/29/2026 Earnings Call Q3 2026 Open →
  • 08/07/2026 Earnings Call Q2 2026 Open →
  • 02/18/2026 Earnings Call Q4 2025 Open →
  • 10/29/2025 Earnings Call Q3 2025 Open →

News on This Stock

  • 10/28/2026 Amrize Ltd (AMRZ): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/11/2026 Amrize Ltd (AMRZ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/01/2026 Amrize Ltd (AMRZ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 08/24/2026 Amrize Ltd (AMRZ): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?